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Abstract. The development of chondrogenic cell lines has led 
to major advances in the understanding of how chondrocyte 
differentiation is regulated, and has uncovered many signal-
ling pathways and gene regulatory mechanisms required to 
maintain normal function. ATDC5 cells are a well established 
in vitro model of endochondral ossification; however, current 
methods are limited for mineralisation studies. In this study 
we demonstrate that culturing cells in the presence of ascorbic 
acid and 10 mM β-glycerophosphate (βGP) significantly 
increases the rate of extracellular matrix (ECM) synthesis 
and reduces the time required for mineral deposition to occur 
to 15 days of culture. Furthermore, the specific expression 
patterns of Col2a1 and Col10a1 are indicative of ATDC5 
chondrogenic differentiation. Fourier transform-infrared 
spectroscopy analysis and transmission electron microscopy 
(TEM) showed that the mineral formed by ATDC5 cultures 
is similar to physiological hydroxyapatite. Additionally, we 
demonstrated that in cultures with βGP, the presence of 
alkaline phosphatase (ALP) is required for this mineralisation 
to occur, further indicating that chondrogenic differentiation 
is required for ECM mineralisation. Together, these results 
demonstrate that when cultured in the presence of ascorbic 
acid and 10 mM βGP, ATDC5 cells undergo chondrogenic 
differentiation and produce a physiological mineralised ECM 
from Day 15 of culture onwards. The rapid and novel method 
for ATDC5 culture described in this study is a major improve-
ment compared with currently published methods and this 
will prove vital in the pursuit of underpinning the molecular 
mechanisms responsible for poor linear bone growth observed 
in a number of chronic diseases such as cystic fibrosis, chronic 
kidney disease, rheumatological conditions and inflammatory 
bowel disease.
Introduction
The growth plate and its primary cell type, the chondrocyte, 
are integral to endochondral ossification and thus the linear 
growth of the long bones (1). The continuing development 
of in vitro chondrocyte cell lines has furthered our under-
standing of the underlying mechanisms of endochondral 
ossification.
The ATDC5 cell line, which was first isolated from 
the differentiating teratocarcinoma stem cell line AT805, 
is commonly used as a model for in vitro chondrocyte 
research (2). To date, the ATDC5 cell line has been utilised 
in approximately 300 studies. Previous studies have detailed 
a well-characterised method of ATDC5 differentiation 
and mineralisation, initially by Shukunami et al (3). This 
method has provided a reliable model of in vitro chondrocyte 
mineralisation for a number of years and has been widely 
used in the field since its publication; however it does contain 
some drawbacks. For example, mineralisation studies require 
a culture time of at least 34 days and a change of culture 
conditions. Both the cell culture medium and the CO2 concen-
tration have to be altered after 21 days of culture to facilitate 
extracellular matrix (ECM) mineralisation 13 days later. 
Since its publication, a number of groups have attempted to 
simplify the culture method. For example, the addition of 
inorganic phosphate to ATDC5 cultures has been shown to 
increase differentiation and the rate of ECM mineralisation 
(4,5). Another study has detailed that the addition of ascorbic 
acid shortened the proliferation phase of the ATDC5 cells 
from 21 to 7 days (6); while the temporal expression of 
markers of chondrogenic differentiation was examined, the 
ECM mineralisation capability of the ATDC5 cells under 
these culture conditions was not.
Therefore, our aim was to develop a culture model for 
ATDC5 cells which produced both consistent chondrogenesis 
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and physiological ECM mineralisation in a reduced time period 
for in vitro experimentation. In this study, β-glycerophosphate 
(βGP) was added throughout the culture period. βGP is cleaved 
by alkaline phosphatase (ALP) and other phosphohydro-
lases produced by the chondrocytes once they have reached 
hypertrophy to release inorganic phosphate, thus mimicking 
the phosphate availability in vivo (3,7,8). It was hypothesised 
that this strategy would facilitate an incremental increase in 
mineral deposition once an appropriate ECM had been depos-
ited. This would thereby increase the rate of mineralisation 
compared with previous methods while retaining the expected 
stages of chondrogenic differentiation as well as crucially, the 
formation of physiological mineral.
Materials and methods
Cell culture. Chondrogenic ATDC5 cells (Riken Cell Bank, 
Ibaraki, Japan) (3) were cultured in a differentiation medium 
[DMEM/F-12 (1:1) with GlutaMAX I containing 5% FBS, 
1% insulin transferrin and selenium, 1% sodium pyruvate 
and 0.5% gentamicin (Invitrogen, Paisley, UK)] at a density 
of 6,000 cells/cm2 in multi-well plates (Iwaki Cell Biology; 
Sterilin, Feltham, UK) (9,10). Cells were left for 6 days to reach 
confluency at which point the medium was supplemented with 
10 mM βGP and 50 µg/ml L-ascorbate-2-phosphate (ascorbic 
acid). Cells were incubated in a humidified atmosphere (37˚C, 
5% CO2) for up to 41 days and the medium was changed every 
second or third day. For levamisole experiments, ATDC5 cells 
were cultured in varying concentrations of levamisole (Sigma, 
Gillingham, UK) (0-1,000 µM) for up to 15 days.
Histochemical staining. Calcium deposition in ATDC5 cells 
was evaluated by Alizarin red staining as described previ-
ously (11). Briefly, cells were fixed in 4% paraformaldehyde 
and then 2% Alizarin red (Sigma, pH 4.2) was added to 
the cell layers for 5 min at room temperature. Cells were 
washed with distilled water (dH20) and images were captured. 
Alizarin red-stained cultures were extracted with 10% cetyl-
pyridinium chloride for 10 min and the optical density (OD) 
of the digests was measured at 570 nm by spectrophotometry 
(Multiskan Ascent; Thermo Electron Corporation, Vantaa, 
Finland). Proteoglycan synthesis was evaluated by staining 
the cell layers with Alcian blue (Sigma). Cells were fixed in 
95% methanol for 20 min and stained with 1% Alcian blue 
8GX in 0.1 M HCl overnight. Cells were washed in dH20 
and images were captured. Alcian blue-stained cultures 
were extracted with 6 M guanidine-HCl for 6 h at room 
temperature and the OD was determined at 630 nm by 
spectrophotometry (11).
Real-time quantitative PCR (qRT-PCR). RNA was extracted 
using the RNeasy Mini kit (Qiagen Ltd., Crawley, West Sussex, 
UK), according to the manufacturer's instructions. For each 
sample, total RNA content was assessed by absorbance at 
260 nm and purity by A260/A280 ratios, and then reverse-
transcribed. cDNA was diluted to 10 ng/µl in nuclease-free 
water (Sigma), and stored at -20˚C. qRT-PCR reactions were 
conducted with a MX3000P qPCR machine (Stratagene, 
Stockport, UK) using a SYBR-Green detection method. 
Primers were designed in-house and synthesised by MWG 
Eurofins, London, UK. Reactions were run in triplicate and 
routinely normalised against GAPDH. Primer sequences: 
Col2a1, forward, 5'-CGGTCCTACGGTGTCAGG-3' and 
reverse, 5'-GCAGAGGACATTCCCAGTGT-3'; Col10a1, 
forward,  5'-CATAAAGGGCCCACTTGCTA-3'  and 
reverse,5'-CAGGAATGCCTTGTTCTCCT-3'; GAPDH 
forward, 5'-TGAGGCCGGTGCTGAGTATGTCG-3' and 
reverse, 5'-CCACAGTCTTCTGGGTGGCAGTG-3'. qRT-PCR 
products were sequenced by the GenePool, University of 
Edinburgh.
Transmission electron microscopy (TEM). ATDC5 cells were 
cultured at 6,000 cells/cm2 on nitrocellulose discs (Nunc, 
Roskilde, Denmark) in mineralising conditions for 15 days. 
Cells were fixed in 2.5% glutaraldehyde in 0.1 M sodium 
cacodylate buffer at 37˚C for 1 h. During processing, the 
cell monolayers were washed in 0.1 M sodium cacodylate, 
post-fixed in 1% osmium tetroxide and dehydrated through 
graded alcohols (35, 70, 95 and 100%). The monolayers were 
then processed to Epon in a vacuum oven at 60˚C. Monolayers 
were viewed using a Phillips CMIRO TEM (FEI Vic Ltd., 
Cambridge, UK) and images were captured on Gatan Orius 
ICD camera (Gatan, Oxford, UK).
Fourier transform-infrared spectroscopy (FTIR). ATDC5 
cells were cultured for 41 days in mineralising conditions 
as previously described. Cell monolayers were fixed in 
95% methanol and embedded in LR White. Spectral images of 
2 µm-thick culture sections were collected using a Spectrum 
Spotlight 100 system (Perkin-Elmer, Waltham, MA, USA) 
with a spectral resolution of 4 µm and 6.25 µm pixel size in 
transmission mode. The collected spectra were truncated, 
base-lined and the contribution of LR White was spectrally 
subtracted using ISYS software (Spectral Dimensions, Olney, 
MD, USA) and then analysed using ISys Chemical Imaging 
software. Spectra extracted from these images were analysed 
using Grams/32 software (Thermo Electron Corporation, 
Waltham, MA, USA). The parameters measured included 
mineral/matrix ratio, carbonate/phosphate ratio, crystallinity 
and collagen maturity (12).
Statistics. Data were analysed by one-way analysis of vari-
ance (ANOVA), with Tukey simultaneous tests used to 
identify differences between individual time-points, using 
SigmaPlot 11.0 software (Systat Software UK Ltd., London, 
UK). Cell culture experiments were repeated at least twice 
and P<0.05 was considered statistically significant.
Results
ATDC5 cells undergo the expected stages of chondrocyte 
differentiation. Images collected by light microscopy over 
a 34-day time-course indicated comparable differentiation 
to previously characterised ATDC5 cultures (3,4). ATDC5 
cell cultures reached confluency 6 days after seeding with no 
extensive ECM formation (Fig. 1A). At this point, ATDC5 
cells were then cultured in the presence of 10 mM βGP and 
50 µg/ml ascorbic acid. This facilitates cell differentiation 
and the secretion of an extensive ECM which assembles 
around the cells as visualised at Day 13 of culture by the 
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Figure 1. Chondrogenic differentiation of ATDC5 cells. ATDC5 cells were grown over a period of 34 days and light microscopy images were collected 
during this time period. (A) Image captured at confluence, Day 6 of culture. (B) Arrows indicate translucent ECM which begins to form in discrete locations 
at Day 13 of culture. (C) The arrows denote opaque regions which represent the onset of mineralisation within the ECM at Day 14. (D) The nodules of ECM 
conjoin over the ECM and mineralisation increases. 
Figure 2. Chondrocyte marker analysis during ATDC5 cell differentiation. (A) The monolayer was fixed following 34 days of culture and stained for GAG 
using Alcian blue. (B) Quantification of Alcian blue staining was conducted over 10 time-points. (C) qRT-PCR analysis of Col2a1 and (D) qRT-PCR analysis 
of Col10a1 transcription, normalised to GAPDH, over 10 time-points in the ATDC5 monolayers. Mean (n=3) ± SEM, with the exception of Col10a1 at Day 10 
where n=2; aP<0.05; bP<0.01; cP<0.001, where all significant differences between consecutive time-points are shown. 
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Figure 3. ATDC5 cell ECM mineralisation. (A) Mineralisation was examined by Alizarin red staining of monolayers fixed at Day 34 of culture. 
(B) Quantification of Alizarin red staining was conducted over 10 time-points. Mean (n=3) ± SEM; aP<0.05; bP<0.01; cP<0.001, where all significant differ-
ences between consecutive time-points are shown. (C) Levamisole, an inhibitor of ALP enzyme activity, was added to ATDC5 cell cultures from when they 
reached confluency. Levamisole dose-dependently inhibited ATDC5 ECM mineralisation as indicated by quantification of Alizarin red staining. (D) Alizarin 
red stained images of the control cells and cells treated with 300 µM levamisole at Day 15 of culture. Data are represented as the means ± SEM (n=3 repli-
cates) in comparison to 0 µM levamisole cP<0.001. 
Figure 4. Analysis of ATDC5 mineral deposition. TEM images of ATDC5 cultures at Day 16 of culture. (A) Collagen fibers are present in the ECM; arrows 
denote collagen fibers. (B) Mineral deposition is noted along collagen fibers; arrows indicate an electron-dense material, likely to be mineralisation spreading 
along the collagen fibers within the ECM. (C) Mineral deposition within the ECM; arrows indicate electron-dense mineralised regions of the ECM. (D) FTIR 
analysis of (a) ATDC5 monolayer at 41 days of culture; (b) mineralised embryonic mouse bone at E14; (c) cortical bone from the tibia of a 4-month-old mouse. 
Absorbances of the phosphate peaks (900-1200 cm-1), which represents mineralisation and the amide-I peak (1585-1725 cm-1), which indicates protein, were 
used to estimate the mineral-to-matrix ratio of the mineralised ECM. Absorbance values for each plot are arbitrary and not to scale. 
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phase contrast images (Fig. 1B) and by Alcian blue staining 
(data not shown). As differentiation continues, these nodules 
increased in area and began to conjoin (Fig. 1C). A large 
proportion of each ATDC5 monolayer was Alcian blue-
positive by Day 34 of culture, indicating that ATDC5 cells 
produced a glycosaminoglycan (GAG)-rich ECM and under-
went chondrogenesis (Fig. 2A). The temporal increase in 
GAG-deposition over a 34-day time-course was established 
by quantifying Alcian blue staining (Fig. 2B). GAG-deposition 
progressively increased from Day 6, such that there were 
significant increases in Alcian blue staining between various 
time-points within the culture period.
To examine the process of chondrogenesis and hypertro-
phic differentiation of the ATDC5 cells during monolayer 
culture, Col2a1 and Col10a1 gene transcription at specific 
time-points was analysed by qRT-PCR. Col2a1 transcrip-
tion increased significantly between each time-point from 
Day 6 to 13; transcription then decreased but even at Day 34, 
transcription was greater compared to Day 6 (by >58-fold, 
P<0.001) (Fig. 2C). Col10a1 transcription also increased 
significantly over the first 4 time-points up to Day 13 over a 
10,000-fold range, which by Day 34 progressed to a greater 
than 50,000-fold increase in transcription compared to that of 
Day 6 (Fig. 2D).
ATDC5 cells mineralise their surrounding ECM, producing 
physiological mineral. Phase contrast images indicated 
mineralisation of the ATDC5 ECM from Day 14 onwards and 
this was confirmed by Alizarin red staining over a 34-day 
time-course (Fig. 1C and D, Fig. 3A and B). Quantification of 
this staining indicated that after an initial delay, presumably 
while early differentiation stages were occurring, calcium 
accumulation increased rapidly from Day 17 to 34 (Fig. 3B) 
(P<0.001).
Levamisole, a well established inhibitor of ALP, inhib-
ited ATDC5 ECM mineralisation at Day 15 of culture at 
concentrations in excess of 300 µM (P<0.001) (Fig. 3C) with 
no apparent alterations in the morphology of the ATDC5 
cells (Fig. 3D) (13). This indicated that the enzyme ALP is 
required, and therefore that chondrogenic differentiation of 
the ATDC5 cells is necessary for effective mineralisation.
FTIR and TEM were adopted as two well recognised 
methods to determine whether the properties of the mineral 
formed in culture is similar to that which is formed by 
mineralised cartilage in vivo (14). ATDC5 cells were shown 
to produce a collagenous ECM by TEM in which banded 
fibers, synonymous with collagen fibers, were present in 
the ECM (Fig. 4A) (15). Along some of the collagen fibers, 
electron-dense regions were present, indicative of the onset of 
mineralisation (Fig. 4B). In some discrete regions of the ECM, 
electron-dense spheres of ~200-500 nm were present which 
were also associated with the collagenous fibers (Fig. 4C); 
these are possibly mineralised matrix vesicles (MVs) (1,8,9). 
These results suggest that ATDC5 cells produce a collagenous 
ECM and that the mineral formed is in alignment with the 
collagen fibrils, as is observed in endochondral ossification. 
ATDC5 cells were cultured for 41 days for FTIR analysis 
(Fig. 4D-a). The FTIR spectra were compared with those 
of E14 embryonic mouse bone (Fig. 4D-b) and 4-month-old 
cortical mouse bone (Fig. 4D-c), and were used to generate 
numerical parameters which may be compared with in vivo 
samples (Table I). The resulting data strongly suggest that the 
mineralisation of the ATDC5 monolayers resembles that of 
embryonic mouse bone.
Discussion
Attempts to unravel the underlying mechanisms of endochon-
dral ossification have been limited by current models. The 
data presented in this manuscript characterise a novel, rapid 
culture method for studying physiological chondrocyte ECM 
mineralisation using ATDC5 cells that we observed to be 
highly reproducible. A mineralisation method for ATDC5 cell 
culture was first described by Shukunami et al (3), however 
its drawbacks have been identified by several other groups 
and thus the method has been gradually developed with time. 
In this study, we cultured ATDC5 cells in the presence of 
ascorbic acid and 10 mM βGP.
ATDC5 cells have previously been cultured with ascorbic 
acid, which facilitates collagen synthesis. This reduces the 
proliferation phase of the cells and promotes their differen-
tiation (6,16). Ascorbic acid has also been shown to promote 
the hypertrophic differentiation of cultured primary chick 
chondrocytes (17). In the present study, cells were cultured 
in the presence of 50 µg/ml ascorbic acid from when they 
reached confluency and in concurrence with previous studies, 
this promoted ECM formation. The increased mRNA expres-
sion of the chondrogenic marker Col2a1 correlated with the 
onset of Alcian blue-stained cartilaginous nodules and the 
increased mRNA expression of Col10a1 with the differen-
tiation of the cells to a hypertrophic phenotype. The delayed 
onset of Col10a1 transcription at Day 10 is consistent with the 
2 stages of differentiation that must occur from Day 6 for the 
cells to become hypertrophic. The observation that Col10a1 
Table I. Mineralisation parameters from FTIR samples.
Sample Mineral-to-matrix ratio Carbonate-to-mineral ratio Crystallinity
A 3.000±0.917 0.008±0.005 1.128±0.009
B 2.200±2.500 0.005±0.002 1.072±0.062
C 6.500±0.900 0.006±0.001 1.130±0.030
Using peak areas from FTIR spectra, the mineral-to-matrix ratio (900-1,200 cm-1/1,585-1,725 cm-1), carbonate-to-mineral ratio (850-
950 cm-1/900-1,200 cm-1) and crystallinity (1,030 cm-1/1,020 cm-1) were calculated for mineralised regions of (A) ATDC5 monolayer grown to 
41 days of culture, (B) mineralised E14 mouse bone and (C) ortical bone from the tibia of a 4-month-old mouse.
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expression preceded the first observations of mineral forma-
tion provides further evidence that the model is able to mimic 
the in vivo endochondral ossification. During differentiation 
the histology of the cultures was similar to that described by 
Shukunami et al (3).
In addition to ascorbic acid, an exogenous phosphate 
source is routinely added to cell cultures to induce and 
stimulate mineralisation of the ECM. βGP is a preferential 
exogenous organic phosphate source as it is a substrate for 
ALP and therefore the cells directly dictate when it is cleaved 
to release inorganic phosphate with their differentiation to a 
hypertrophic phenotype. In this study we cultured ATDC5 
cells in the presence of 10 mM βGP and observed mineral 
formation from Day 15 of culture upon collagen fibrils and 
within MVs. However, in a number of osteoblast and chon-
drocyte cultures, the growth of cells in the presence of βGP 
has been shown to lead to the formation of sporadic mineral 
formation on the cell surface and in the culture medium and 
not upon collagen fibrils which is regarded to be dystrophic 
mineralisation and not physiological hydroxyapatite (18,19).
In the present study we showed that the presence of ALP 
is necessary for βGP-induced ATDC5 mineralisation. This is 
consistent with previous studies in which the activity of ALP 
has been investigated in ATDC5 cells (3). Furthermore, the 
addition of levamisole, a potent inhibitor of ALP, to ATDC5 
cultures inhibited their ECM mineralisation. Mineralisation 
was also inhibited in cells cultured in the presence of βGP 
and in the absence of insulin, which is required for their 
differentiation (data not shown) (20). This result, therefore, 
suggests that mineral formation is dependent upon both 
chondrogenic differentiation and the subsequent presence 
of ALP. Additionally, the inhibition of ECM mineralisation 
when ATDC5 cells were cultured without insulin further 
emphasises that the mineral formed is not dystrophic and is 
dependent on their differentiation status.
Although routinely used as indicators of mineralisa-
tion, Alizarin red and von Kossa staining are not sufficient 
to conclude that mineralisation is physiological since the 
presence of calcium and/or phosphate does not indicate HA 
formation per se (21). For this reason, we adopted FTIR and 
TEM to examine whether or not the mineral formed in culture 
is physiological (14).
Shukunami et al (3) have previously used TEM for 
ATDC5 analysis and reported the presence of extremely 
dark calcium-containing spherites which they identified as 
mineralised MVs in discrete regions between the cells, associ-
ated with collagenous fibers. In the present study, structures 
were noted in our TEM analysis which were indistinguishable 
in shape and size from those reported by Shukunami et al 
(3). The MVs derived from ATDC5 cells are of a similar size 
and appearance to MVs derived from in vivo tissues including 
chicken growth plate chondrocytes and rat epiphyseal hyper-
trophic chondrocytes (22). These results indicate that the 
ultrastructure of the collagenous fibrils appears as expected 
and that mineralisation of ATDC5 cultures appears to form in 
a physiological manner.
Furthermore, in this study we showed that the spectra of 
the ATDC5 monolayer more closely resembled that of the 
developing embryonic bone compared to the fully developed 
cortical bone. The mineral-to-matrix ratio of the ATDC5 
cultures, a key determinant of mineral composition is similar 
to the values for mineralised embryonic bone, E14, which is 
the earliest point at which mineralisation occurs in the mouse 
(23). The mineral-matrix ratios in other publications provide 
additional comparisons: in 10-day-old and 10-week-old 
wild-type mouse calcified growth plate cartilage the ratios 
have been calculated as 2.7 and 5.48, respectively (24,25). 
There is a considerable variation in these parameters, but 
the mineral-matrix ratio within the ATDC5 monolayer is 
within the expected region. The ATDC5 monolayer model 
characterised by Shukunami et al (3) was analysed by FTIR 
and spectra were compared with those of cultured primary 
rabbit chondrocytes, resulting in spectra which were almost 
super-imposable. These spectra show that the absorbance is 
greater in the amide-range compared to the phosphate-range, 
thus although the mineral-to matrix ratio is not provided, 
it is certainly less than those reported in the present study. 
Therefore, ECM mineralisation is greater in this ATDC5 
model compared to the method generated by Shukunami et al 
(3). If mineralisation in the cultures is ectopic and mineral is 
accumulated simply due to ALP cleavage of βGP, the ratio 
of mineral-to-matrix would be expected to be extremely 
high, which is not the case. A study by Huitema et al (26), 
demonstrated this; inorganic phosphate was added to medium 
conditioned by ATDC5 cells which generated flat, miner-
alised structures, with extremely small amide-I peaks, relative 
to phosphate peaks.
The minera l ised product of the ATDC5 mono-
layer produced a phosphate peak with a clear shoulder 
at approximately 1,130 cm-1. This is characteristic of the 
hydroxyapatite containing acid phosphate which is gradually 
lost as the crystal matures; thus both the ATDC5 monolayer 
and the embryonic bone contain this peak, which is absent 
in the mature hydroxyapatite sample (27,28). The values 
obtained from the carbonate substitution and crystallinity 
are within the range of biologically relevant in vivo samples, 
which also indicates that this ATDC5 model generates physi-
ologically relevant mineral (24,29).
The development and characterisation of a rapidly miner-
alising chondrocyte model has the potential to assist us in 
better understanding the underpinning molecular mechanisms 
responsible for poor linear bone growth which is observed in 
a number of chronic diseases such as cystic fibrosis, chronic 
kidney disease, rheumatological conditions and inflammatory 
bowel disease. Chondrocyte models, including the ATDC5 
cell line, have proved invaluable for determining the effects of 
pro-inflammatory cytokines and glucocorticoids on chondro-
cyte proliferation, differentiation and gene expression (9,10). 
However, the absence of a practical and accessible in vitro 
chondrocyte mineralisation model has hindered a fuller 
appreciation of how cartilage mineralisation and endochon-
dral ossification are disrupted by factors e.g. cytokines and 
drugs, that are responsible for impaired linear bone growth in 
children.
In conclusion, in this study we developed and character-
ised an improved and rapid method of ATDC5 differentiation 
which develops a physiologic mineralised ECM 15 days after 
seeding. To our knowledge, this is the earliest report of 
mineralisation in which physiological attributes of the mineral 
have been characterised.
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